Article

Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patients

2020-08-07

Abstract excerpt

<h4>ABSTRACT</h4> Commercial availability of serological tests to evaluate immunoglobulins (Ig) towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has grown exponentially since the onset of COVID-19 (Coronavirus Disease 2019) outbreak. Their thorough validation is of extreme importance before using them as epidemiological tools to infer population seroprevalence, and as complementary diagnostic t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04328b31-2d7a-5f68-b800-bb815e5e6208
DOI: 10.1101/2020.08.06.20168856

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patientsDOI 10.1101/2020.08.06.20168856Read

Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology testsSemantic proximity Read

Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunitySemantic proximity Read

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

A comparative review of immunoassays for COVID-19 detectionSemantic proximity Read

SARS-CoV-2 Antigen Rapid Detection Tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccinationSemantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Role of Anti-SARS-CoV-2 antibodies in different cohorts: Can they provide clues for appropriate patient triaging?Semantic proximity Read

Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workersSemantic proximity Read

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationSemantic proximity Read